Strs Ohio Decreases Stake in Danaher Corporation $DHR

Strs Ohio reduced its holdings in shares of Danaher Corporation (NYSE:DHR) by 11.8% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 286,375 shares of the conglomerate’s stock after selling 38,316 shares during the quarter. Strs Ohio’s holdings in Danaher were worth $54,297,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new position in Danaher in the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter valued at about $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher during the 2nd quarter valued at about $26,000. Hilton Head Capital Partners LLC bought a new stake in shares of Danaher in the fourth quarter worth approximately $27,000. Finally, Clal Insurance Enterprises Holdings Ltd raised its holdings in shares of Danaher by 71.6% during the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 2.1%

Shares of DHR stock opened at $197.85 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a market cap of $140.03 billion, a P/E ratio of 38.27, a P/E/G ratio of 2.47 and a beta of 0.79. The company has a 50 day simple moving average of $178.74 and a two-hundred day simple moving average of $200.56.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The business had revenue of $5.95 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter last year, the company posted $1.88 EPS. The company’s revenue was up 3.7% compared to the same quarter last year. On average, research analysts expect that Danaher Corporation will post 8.44 earnings per share for the current year.

Danaher Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 annualized dividend and a yield of 0.8%. Danaher’s payout ratio is 30.95%.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on the stock. Wolfe Research downgraded shares of Danaher from an “outperform” rating to a “peer perform” rating in a research report on Monday, June 1st. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 target price for the company. Weiss Ratings lowered shares of Danaher from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday. TD Cowen lowered their price target on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a report on Wednesday, April 22nd. Finally, Barclays dropped their price target on Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $233.61.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.